Literature DB >> 20442290

Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells.

Sun-Hee Kim1, Dianren Xia, Sang-Wook Kim, Vijaykumar Holla, David G Menter, Raymond N Dubois.   

Abstract

Human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) is a scaffolding protein that is implicated in regulating diverse cellular processes, such as cellular attachment, motility, cell cycle progression, apoptosis, and inflammation. Here, we identify HEF1 as a novel hypoxia-inducible factor-1alpha (HIF-1alpha)-regulated gene and reveal that HEF1 mediates hypoxia-induced migration of colorectal carcinoma cells. HEF1 is highly expressed in cultured colorectal carcinoma cells exposed to hypoxia and in the hypoxic areas of human colorectal cancer (CRC) specimens. Moreover, our data show that HIF-1alpha mediates the effects of hypoxia on induction of HEF1 expression via binding to a hypoxia-responsive element of the HEF1 promoter. Importantly, the induction of HEF1 expression significantly enhances hypoxia-stimulated HIF-1alpha transcriptional activity by modulating the interaction between HIF-1alpha and its transcriptional cofactor p300. Inhibition of HEF1 expression also reduced the levels of hypoxia-inducible genes, including those that regulate cell motility. Cell migration was reduced dramatically following knockdown of HEF1 expression under hypoxic conditions. Thus, this positive feedback loop may contribute to adaptive responses of carcinoma cells encountering hypoxia during cancer progression. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442290      PMCID: PMC2871069          DOI: 10.1158/0008-5472.CAN-09-2110

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

Review 1.  Generating specificity and diversity in the transcriptional response to hypoxia.

Authors:  Urban Lendahl; Kian Leong Lee; Henry Yang; Lorenz Poellinger
Journal:  Nat Rev Genet       Date:  2009-11-03       Impact factor: 53.242

Review 2.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

Review 3.  Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer.

Authors:  A Giatromanolaki; A L Harris
Journal:  Anticancer Res       Date:  2001 Nov-Dec       Impact factor: 2.480

4.  YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

Authors:  Eun-Jin Yeo; Yang-Sook Chun; Young-Suk Cho; Jinho Kim; June-Chul Lee; Myung-Suk Kim; Jong-Wan Park
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

5.  Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway.

Authors:  G A van Seventer; H J Salmen; S F Law; G M O'Neill; M M Mullen; A M Franz; S B Kanner; E A Golemis; J M van Seventer
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

6.  atRA Regulation of NEDD9, a gene involved in neurite outgrowth and cell adhesion.

Authors:  D C Knutson; M Clagett-Dame
Journal:  Arch Biochem Biophys       Date:  2008-06-15       Impact factor: 4.013

Review 7.  NO-independent, haem-dependent soluble guanylate cyclase stimulators.

Authors:  Johannes-Peter Stasch; Adrian J Hobbs
Journal:  Handb Exp Pharmacol       Date:  2009

8.  Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression.

Authors:  Tianqing Kong; Holger K Eltzschig; Jorn Karhausen; Sean P Colgan; C Simon Shelley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-02       Impact factor: 11.205

9.  HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells.

Authors:  Dianren Xia; Vijaykumar R Holla; Dingzhi Wang; David G Menter; Raymond N DuBois
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

10.  Regulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesion.

Authors:  Mingzhe Zheng; Paula J McKeown-Longo
Journal:  J Biol Chem       Date:  2002-08-19       Impact factor: 5.157

View more
  34 in total

Review 1.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 2.  Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.

Authors:  Nanduri R Prabhakar; Gregg L Semenza
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  VHL inactivation induces HEF1 and Aurora kinase A.

Authors:  Jianyong Xu; Huapeng Li; Bo Wang; Yan Xu; Jiayin Yang; Xiaofei Zhang; Sarah K Harten; Deepa Shukla; Patrick H Maxwell; Duanqing Pei; Miguel A Esteban
Journal:  J Am Soc Nephrol       Date:  2010-09-23       Impact factor: 10.121

Review 4.  Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.

Authors:  Elena Shagisultanova; Anna V Gaponova; Rashid Gabbasov; Emmanuelle Nicolas; Erica A Golemis
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

5.  Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.

Authors:  Jin Dai; Peter G Van Wie; Leonard Yenwong Fai; Donghern Kim; Lei Wang; Pratheeshkumar Poyil; Jia Luo; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-20       Impact factor: 4.219

6.  NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Authors:  Yann Wallez; Peter D Mace; Elena B Pasquale; Stefan J Riedl
Journal:  Genes Cancer       Date:  2012-05

7.  Inhibition of Hypoxia-Induced Cell Motility by p16 in MDA-MB-231 Breast Cancer Cells.

Authors:  Liyuan Li; Yi Lu
Journal:  J Cancer       Date:  2010-09-01       Impact factor: 4.207

8.  The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss.

Authors:  Yan Feng; Ye Wang; Zuoyun Wang; Zhaoyuan Fang; Fei Li; Yijun Gao; Hongyan Liu; Tian Xiao; Fuming Li; Yang Zhou; Qiwei Zhai; Xiaolong Liu; Yihua Sun; Nabeel Bardeesy; Kwok-kin Wong; Haiquan Chen; Zhi-qi Xiong; Hongbin Ji
Journal:  Cancer Res       Date:  2012-10-16       Impact factor: 12.701

9.  β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma.

Authors:  Ruhee Dere; Ashley Lyn Perkins; Tasneem Bawa-Khalfe; Darius Jonasch; Cheryl Lyn Walker
Journal:  J Am Soc Nephrol       Date:  2014-10-13       Impact factor: 10.121

10.  Hypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studies.

Authors:  Yan Ren; Piliang Hao; Bamaprasad Dutta; Esther Sok Hwee Cheow; Kae Hwan Sim; Chee Sian Gan; Sai Kiang Lim; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2012-11-30       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.